Prem S. Shah - 30 Nov 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Group President
Signature
/s/ Prem S. Shah
Issuer symbol
CVS
Transactions as of
30 Nov 2024
Net transactions value
+$53,596,968
Form type
4
Filing time
03 Dec 2024, 17:14:53 UTC
Previous filing
03 Apr 2024
Next filing
18 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 42,344 30 Nov 2024 Direct
holding CVS Common Stock (Restricted) 37,057 30 Nov 2024 Direct
holding CVS ESOP Common Stock 4,969 30 Nov 2024 Direct
holding CVS Stock Unit (deferred) 3,468 30 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Premium Stock Option Award $53,596,968 +746,268 $71.82 746,268 30 Nov 2024 Common Stock 746,268 $71.82 Direct F12
holding CVS Phantom Stock Credits 39,586 30 Nov 2024 Common Stock 39,586 $1.00 Direct F2, F3
holding CVS Stock Option 846 30 Nov 2024 Common Stock 846 $62.21 Direct F4
holding CVS Stock Option 9,469 30 Nov 2024 Common Stock 9,469 $54.19 Direct F5
holding CVS Stock Option 28,596 30 Nov 2024 Common Stock 28,596 $58.34 Direct F6
holding CVS Stock Option 26,580 30 Nov 2024 Common Stock 26,580 $75.24 Direct F7
holding CVS Stock Option 28,723 30 Nov 2024 Common Stock 28,723 $74.30 Direct F8
holding CVS Stock Option 41,580 30 Nov 2024 Common Stock 41,580 $101.09 Direct F9
holding CVS Stock Option 89,073 30 Nov 2024 Common Stock 89,073 $74.31 Direct F10
holding CVS Stock Option 62,695 30 Nov 2024 Common Stock 62,695 $79.56 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F5 Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
F6 Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F7 Option became exercisable in three equal installments, commencing on 8/31/2021.
F8 Option became exercisable in three equal installments commencing 04/01/2022.
F9 Option became exercisable in four equal installments, commencing 4/1/2023.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2024.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2025.
F12 Option becomes exercisable in three equal annual installments, commencing 11/30/2025.